The present invention relates to sodium channel inhibitors of Formula (I):
in which R
1
, R
2
, R
3
, R
4
, R
5
, X, Y, and Z are as defined herein, and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes.
The invention also relates to methods for the preparation of the compounds, and to pharmaceutical compositions containing such compounds.
本发明涉及具有以下结构的
钠通道
抑制剂(I):其中R1、R2、R3、R4、R5、X、Y和Z如本文所定义,并且其在治疗各种疾病状态中的使用,包括心血管疾病和糖尿病。该发明还涉及制备这些化合物的方法,以及含有这些化合物的药物组合物。